Rosenblum Silverman Sutton S F Inc. CA lessened its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 0.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 42,530 shares of the pharmacy operator’s stock after selling 100 shares during the quarter. Walgreens Boots Alliance accounts for 1.3% of Rosenblum Silverman Sutton S F Inc. CA’s investment portfolio, making the stock its 29th biggest position. Rosenblum Silverman Sutton S F Inc. CA’s holdings in Walgreens Boots Alliance were worth $3,331,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently modified their holdings of the business. State Street Corp lifted its stake in shares of Walgreens Boots Alliance by 1.8% during the first quarter. State Street Corp now owns 37,612,843 shares of the pharmacy operator’s stock worth $3,123,757,000 after purchasing an additional 677,743 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of Walgreens Boots Alliance by 5.9% in the first quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock worth $2,727,932,000 after acquiring an additional 1,824,300 shares in the last quarter. Nordea Investment Management AB lifted its stake in shares of Walgreens Boots Alliance by 26.5% in the first quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock worth $760,267,000 after acquiring an additional 1,917,082 shares in the last quarter. TIAA CREF Investment Management LLC lifted its stake in shares of Walgreens Boots Alliance by 22.4% in the first quarter. TIAA CREF Investment Management LLC now owns 5,269,500 shares of the pharmacy operator’s stock worth $437,632,000 after acquiring an additional 962,959 shares in the last quarter. Finally, Legal & General Group Plc lifted its stake in shares of Walgreens Boots Alliance by 5.2% in the second quarter. Legal & General Group Plc now owns 4,550,856 shares of the pharmacy operator’s stock worth $356,368,000 after acquiring an additional 223,186 shares in the last quarter. Institutional investors own 60.24% of the company’s stock.

In other news, Director John Anthony Lederer purchased 20,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, October 26th. The shares were bought at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the transaction, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 13.50% of the company’s stock.

Several research firms recently commented on WBA. Needham & Company LLC set a $94.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Monday, July 17th. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Thursday, October 26th. Leerink Swann cut Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a research note on Wednesday. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. Finally, Royal Bank Of Canada began coverage on Walgreens Boots Alliance in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price target on the stock. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The firm had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. During the same quarter in the previous year, the business earned $1.07 EPS. The business’s quarterly revenue was up 5.3% compared to the same quarter last year.

Walgreens Boots Alliance announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its shares are undervalued.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.41%. Walgreens Boots Alliance’s dividend payout ratio is 42.33%.

COPYRIGHT VIOLATION NOTICE: “Rosenblum Silverman Sutton S F Inc. CA Sells 100 Shares of Walgreens Boots Alliance Inc (WBA)” was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://theolympiareport.com/2017/11/02/rosenblum-silverman-sutton-s-f-inc-ca-sells-100-shares-of-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.